Huntington National Bank lowered its position in Colgate-Palmolive Company (NYSE:CL – Free Report) by 6.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 173,855 shares of the company’s stock after selling 12,900 shares during the quarter. Huntington National Bank’s holdings in Colgate-Palmolive were worth $13,738,000 as of its most recent SEC filing.
A number of other institutional investors have also added to or reduced their stakes in the stock. HighPoint Advisor Group LLC lifted its holdings in Colgate-Palmolive by 0.7% during the 4th quarter. HighPoint Advisor Group LLC now owns 15,877 shares of the company’s stock worth $1,255,000 after purchasing an additional 109 shares in the last quarter. Sunpointe LLC lifted its holdings in Colgate-Palmolive by 4.0% during the 4th quarter. Sunpointe LLC now owns 3,056 shares of the company’s stock worth $241,000 after purchasing an additional 117 shares in the last quarter. Capital Advisors Inc. OK lifted its holdings in Colgate-Palmolive by 1.4% during the 4th quarter. Capital Advisors Inc. OK now owns 9,595 shares of the company’s stock worth $758,000 after purchasing an additional 129 shares in the last quarter. Stratos Wealth Advisors LLC lifted its holdings in Colgate-Palmolive by 4.5% during the 3rd quarter. Stratos Wealth Advisors LLC now owns 3,015 shares of the company’s stock worth $241,000 after purchasing an additional 130 shares in the last quarter. Finally, CYBER HORNET ETFs LLC lifted its holdings in Colgate-Palmolive by 5.9% during the 4th quarter. CYBER HORNET ETFs LLC now owns 2,357 shares of the company’s stock worth $186,000 after purchasing an additional 131 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Analyst Upgrades and Downgrades
A number of analysts recently issued reports on CL shares. Jefferies Financial Group increased their price objective on Colgate-Palmolive from $85.00 to $91.00 and gave the stock a “hold” rating in a report on Monday, February 2nd. JPMorgan Chase & Co. increased their price objective on Colgate-Palmolive from $95.00 to $96.00 and gave the stock an “overweight” rating in a report on Monday, May 4th. Bank of America dropped their price objective on Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating on the stock in a report on Friday, April 10th. Citigroup increased their price objective on Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a report on Monday, February 2nd. Finally, UBS Group increased their price objective on Colgate-Palmolive from $98.00 to $100.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Twelve equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $95.88.
Colgate-Palmolive Stock Performance
Shares of CL opened at $91.69 on Friday. The company has a market cap of $73.37 billion, a PE ratio of 35.68, a price-to-earnings-growth ratio of 4.74 and a beta of 0.31. The company has a current ratio of 1.02, a quick ratio of 0.67 and a debt-to-equity ratio of 16.33. The stock has a 50-day moving average price of $86.24 and a 200-day moving average price of $85.60. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $99.33.
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its quarterly earnings results on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.94 by $0.03. The firm had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.22 billion. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The company’s revenue for the quarter was up 8.4% on a year-over-year basis. During the same quarter last year, the company posted $0.91 EPS. As a group, equities analysts forecast that Colgate-Palmolive Company will post 3.82 earnings per share for the current fiscal year.
Colgate-Palmolive Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, May 15th. Stockholders of record on Monday, April 20th were given a dividend of $0.53 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. The ex-dividend date was Monday, April 20th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.3%. Colgate-Palmolive’s dividend payout ratio is 82.49%.
About Colgate-Palmolive
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
